Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 7, 2013
November 14, 2024
ad5abb22-0ad2-4152-a7b3-c9de659f6843
Related Documents
Expedited Programs for Serious Conditions | Drugs and Biologics
Guidance DocumentMay 30, 2014Center for Drug Evaluation and Research
Dear Health Care Provider Letters: Improving Communication of Important Safety Information
Guidance DocumentJanuary 2, 2014Center for Drug Evaluation and Research
CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports
Guidance DocumentMarch 5, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.